Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Comparative Study of Responses to Retina Questions from Either Experts, Expert-Edited Large Language Models, or Expert-Edited Large Language Models Alone.
Tailor PD, Dalvin LA, Chen JJ, Iezzi R, Olsen TW, Scruggs BA, Barkmeier AJ, Bakri SJ, Ryan EH, Tang PH, Parke DW 3rd, Belin PJ, Sridhar J, Xu D, Kuriyan AE, Yonekawa Y, Starr MR. Tailor PD, et al. Among authors: kuriyan ae. Ophthalmol Sci. 2024 Feb 6;4(4):100485. doi: 10.1016/j.xops.2024.100485. eCollection 2024 Jul-Aug. Ophthalmol Sci. 2024. PMID: 38660460 Free PMC article.
Reply.
Berkowitz ST, Finn AP, Parikh R, Kuriyan AE, Patel S. Berkowitz ST, et al. Among authors: kuriyan ae. Ophthalmology. 2024 Apr 2:S0161-6420(24)00165-9. doi: 10.1016/j.ophtha.2024.02.026. Online ahead of print. Ophthalmology. 2024. PMID: 38573247 No abstract available.
Assessing ChatGPT-3.5 Versus ChatGPT-4 Performance in Surgical Treatment of Retinal Diseases: A Comparative Study.
Momenaei B, Wakabayashi T, Shahlaee A, Durrani AF, Pandit SA, Wang K, Mansour HA, Abishek RM, Xu D, Sridhar J, Yonekawa Y, Kuriyan AE. Momenaei B, et al. Among authors: kuriyan ae. Ophthalmic Surg Lasers Imaging Retina. 2024 Mar 1:1-2. doi: 10.3928/23258160-20240227-02. Online ahead of print. Ophthalmic Surg Lasers Imaging Retina. 2024. PMID: 38531015 Free article. No abstract available.
Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema.
Durrani AF, Momenaei B, Wakabayashi T, Vemula S, Pandit SA, Hsu J, Ho AC, Spirn MJ, Klufas MA, Garg SJ, Vander JF, Regillo CD, Chiang A, Kuriyan AE, Yonekawa Y. Durrani AF, et al. Among authors: kuriyan ae. Br J Ophthalmol. 2024 Feb 12:bjo-2023-324394. doi: 10.1136/bjo-2023-324394. Online ahead of print. Br J Ophthalmol. 2024. PMID: 38346854
Cell therapy for retinal disease.
Yalla GR, Kuriyan AE. Yalla GR, et al. Among authors: kuriyan ae. Curr Opin Ophthalmol. 2024 May 1;35(3):178-184. doi: 10.1097/ICU.0000000000001034. Epub 2024 Jan 24. Curr Opin Ophthalmol. 2024. PMID: 38276971 Review.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2023 Dec 28:S0161-6420(23)00933-8. doi: 10.1016/j.ophtha.2023.12.026. Online ahead of print. Ophthalmology. 2023. PMID: 38158159 Free article.
Rates of Ocular Adverse Events after Intravitreal Faricimab Injections.
Momenaei B, Wang K, Kazan AS, Oh GJ, Ni RL, Wakabayashi T, Durrani AF, Kuriyan AE, Klufas MA, Garg SJ, Yonekawa Y, Hsu J. Momenaei B, et al. Among authors: kuriyan ae. Ophthalmol Retina. 2024 Mar;8(3):311-313. doi: 10.1016/j.oret.2023.12.001. Epub 2023 Dec 7. Ophthalmol Retina. 2024. PMID: 38070673 No abstract available.
157 results